PMID: 42251858

Cagrilintide-semaglutide: a new option for patients with type 2 diabetes.

Scheen André J

The lancet. Diabetes & endocrinology · 2026

Vol. 14, Issue 8, pp. 621-624

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.